Cargando…

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, at the end of 2019, and there are currently no specific antiviral treatments or vaccines available. SARS-CoV-2 has been shown to use the same cell entry receptor as SARS-CoV, angiotensin-converting enzyme 2 (ACE2)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Lei, Changhai, Qian, Kewen, Li, Tian, Zhang, Sheng, Fu, Wenyan, Ding, Min, Hu, Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265355/ https://www.ncbi.nlm.nih.gov/pubmed/32332765 http://dx.doi.org/10.1038/s41467-020-16048-4

Ejemplares similares

Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2
por: Zhang, Yongjing, et al.
Publicado: (2021)

Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions
por: Zheng, Yue, et al.
Publicado: (2020)

Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
por: Zheng, Yue, et al.
Publicado: (2021)

Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein
por: Johnson, Marc C., et al.
Publicado: (2020)

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
por: Crawford, Katharine H. D., et al.
Publicado: (2020)

Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/Nanoparticles
por: Alkhaldi, Soha Y., et al.
Publicado: (2023)

The role of pseudotype neutralization assays in understanding SARS CoV-2
por: Cantoni, Diego, et al.
Publicado: (2021)

CAR Macrophages for SARS-CoV-2 Immunotherapy
por: Fu, Wenyan, et al.
Publicado: (2021)

Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein
por: Tandon, Ritesh, et al.
Publicado: (2020)

Engineered soluble ACE2 receptor: Responding to change with change
por: Li, Guangyao, et al.
Publicado: (2023)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021)

GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus
por: Yeh, Hsin, et al.
Publicado: (2022)

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus
por: Wang, Nan, et al.
Publicado: (2020)

Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus
por: Fu, Xinping, et al.
Publicado: (2020)

Construction of SARS-CoV-2 spike-pseudotyped retroviral vector inducing syncytia formation
por: Lee, Se Yeong, et al.
Publicado: (2022)

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
por: Schmidt, Fabian, et al.
Publicado: (2020)

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
por: Schmidt, Fabian, et al.
Publicado: (2020)

An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants
por: Liu, Juan, et al.
Publicado: (2023)

Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis
por: Hou, Yajing, et al.
Publicado: (2021)

Unique Aggregation of Retroviral Particles Pseudotyped with the Delta Variant SARS-CoV-2 Spike Protein
por: Petersen, Jennifer D., et al.
Publicado: (2022)

Therapeutic antibodies under development for SARS‐CoV‐2
por: Ma, Zetong, et al.
Publicado: (2021)

Neutral evolution test of the spike protein of SARS-CoV-2 and its implications in the binding to ACE2
por: López-Cortés, Georgina I., et al.
Publicado: (2021)

In planta deglycosylation improves the SARS-CoV-2 neutralization activity of recombinant ACE2-Fc
por: Izadi, Shiva, et al.
Publicado: (2023)

Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
por: Yi, Chunyan, et al.
Publicado: (2020)

Insect cell expression and purification of recombinant SARS‐COV‐2 spike proteins that demonstrate ACE2 binding
por: Struble, Lucas R., et al.
Publicado: (2022)

The Delta variant SARS-CoV-2 spike protein uniquely promotes aggregation of pseudotyped viral particles
por: Petersen, Jennifer D., et al.
Publicado: (2022)

Protocol to evaluate the inflammatory response in human macrophages induced by SARS-CoV-2 spike-pseudotyped VLPs
por: Ouyang, Maggie Jing, et al.
Publicado: (2023)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiangdong, et al.
Publicado: (2020)

Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity
por: Phelan, Thomas, et al.
Publicado: (2021)

Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
por: Francesconi, Oscar, et al.
Publicado: (2022)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiandong, et al.
Publicado: (2021)

Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
por: Temperton, Nigel J., et al.
Publicado: (2005)

Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2
por: Wei, Shuangshi, et al.
Publicado: (2021)

Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic
por: Qian, Kewen, et al.
Publicado: (2020)

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
por: Ge, Jiwan, et al.
Publicado: (2021)

A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency
por: Leach, Adam, et al.
Publicado: (2021)

Dual-detection fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike RBD-ACE2 blocking neutralizing antibody
por: Duan, Xuejun, et al.
Publicado: (2022)

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
por: Zhang, Li, et al.
Publicado: (2021)

Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
por: Zettl, Ferdinand, et al.
Publicado: (2020)

Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro
por: Yang, Ren, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pidgooqjqkus7bacefn20hhifb